Academic Journal
European expert consensus on cancer recurrence and progression data collection by population based cancer registries.
| Τίτλος: | European expert consensus on cancer recurrence and progression data collection by population based cancer registries. |
|---|---|
| Συγγραφείς: | Hawkins ST; Northern Ireland Cancer Registry (NICR), Centre for Public Health, Queen's University, Belfast, United Kingdom., Mitchell HJ; Northern Ireland Cancer Registry (NICR), Centre for Public Health, Queen's University, Belfast, United Kingdom. Electronic address: helen.mitchell@qub.ac.uk., Bennett D; Northern Ireland Cancer Registry (NICR), Centre for Public Health, Queen's University, Belfast, United Kingdom., Maso LD; Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Farré X; Public Health Agency of Catalonia, Lleida, Catalonia, Spain., Giusti F; Umbria Cancer Registry Perugia, Italy., Graham K; National Disease Registration Service, NHS England, London, United Kingdom., Huws DW; Welsh Cancer Intelligence & Surveillance Unit (WCISU), Public Health Wales, Cardiff, Wales, United Kingdom; Population Data Science, Swansea University, Swansea, Wales, United Kingdom., Lai J; National Disease Registration Service, NHS England, London, United Kingdom., Lyratzopoulos G; Epidemiology of Cancer Healthcare & Outcomes (ECHO), Department of Behavioural Science and Health, University College London, United Kingdom., Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute Dr. Josep Trueta (IDiBGi-CERCA), Josep Carreras Leukaemia Research Institute (IJC), Girona, Spain., Martos C; Joint Research Centre, European Commission, Ispra, VA 21027, Italy; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain., Manson C; Scottish Cancer Registry, Public Health Scotland, Edinburgh, Scotland, United Kingdom., Michalek I; Department of Cancer Pathology, Maria Sklodowska-Curie National Research Institute of Oncology (MSCI), Warsaw, Poland., Morgan E; Cancer Surveillance Branch International Agency for Research on Cancer (IARC/WHO), Lyon, France., Morrison D; Scottish Cancer Registry, Public Health Scotland, Edinburgh, Scotland, United Kingdom., Mousavi M; Cancer Registry of Eastern Switzerland, Cancer League of Eastern Switzerland, St Gallen, Switzerland., Carvalho RN; Joint Research Centre, European Commission, Ispra, VA 21027, Italy., Nennecke A; Hamburg Cancer Registry, Hamburg, Germany., Ortelli L; Ticino Cancer Registry, Locarno, Switzerland., Randi G; Piksel S.r.l, Milan, Italy., Rous B; National Disease Registration Service, NHS England, London, United Kingdom., Smith K; Scottish Cancer Registry, Public Health Scotland, Edinburgh, Scotland, United Kingdom., Trojanowski M; Greater Poland Cancer Centre, Greater Poland Cancer Registry, Poznan, Poland; European Network of Cancer Registries (ENCR) Steering Committee, United Kingdom., Eycken LV; European Network of Cancer Registries (ENCR) Steering Committee, United Kingdom; Belgian Cancer Registry, Brussels, Belgium., Neamtiu L; Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Verdoodt F; Belgian Cancer Registry, Brussels, Belgium., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands., Wicker T; Hamburg Cancer Registry, Hamburg, Germany., Zadnik V; Slovenian Cancer Registry, Ljubljana, Slovenia., Gavin AT; Northern Ireland Cancer Registry (NICR), Centre for Public Health, Queen's University, Belfast, United Kingdom. |
| Πηγή: | Cancer epidemiology [Cancer Epidemiol] 2026 Jun; Vol. 102, pp. 103067. Date of Electronic Publication: 2026 Apr 06. |
| Τύπος έκδοσης: | Journal Article; Consensus Statement |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101508793 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-783X (Electronic) Linking ISSN: 18777821 NLM ISO Abbreviation: Cancer Epidemiol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Amsterdam : Elsevier |
| Ιατρικοί όροι (MeSH): | Registries*/statistics & numerical data , Neoplasm Recurrence, Local*/epidemiology , Neoplasms*/epidemiology , Neoplasms*/pathology , Neoplasms*/therapy , Data Collection*/methods , Data Collection*/standards, Europe/epidemiology ; Humans ; Disease Progression ; Consensus |
| Περίληψη: | Background: As cancer survival improves, the risk of recurrence and progression (RP) places increasing demands on services. Population based cancer registries (PBCR) recognise the importance of recording these data items and seek defined standardised variables for routine collection of RP events. Methods: Experts from 14 European countries under direction of the European Network of Cancer Registries (ENCR) defined RP for solid and haematological malignancies, standardised variables and coding formats for PBCRs. A seven-step modified-nominal group technique was used. A survey of RP data recording in 2023, an ENCR workshop in 2023 which included wider representation than from Europe and consultation with all ENCR members followed. Results: Definitions were agreed with a tiered approach to data collection and guidance prepared: Cancer recurrence defined as cancer return after a disease-free period post tumour-reductive treatment (TRT) where cancer had a complete clinical or microscopic treatment response. Cancer progression - an increased disease load post TRT where a verified complete response was not achieved. Transformation where tumour changes from indolent to aggressive is covered in RP definitions. Survey responses indicated 31% of PBCRs collect data on RP for all cancer sites 11% for selected sites. Many identified additional resources, training and better access to clinical data required to collect RP data. Guideline implementation began January 2025 irrespective of primary diagnosis date. Conclusion: RP data, standardised and collected by adequately resourced PBCRs, is a key step in quantifying service needs and outcomes of this increasing group of cancer patients. Registries need adequate resources to collect RP data. (Copyright © 2026 The Authors. Published by Elsevier Ltd.. All rights reserved.) |
| Competing Interests: | Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper |
| Contributed Indexing: | Keywords: Cancer; European; Guidelines; Progression; Recurrence; Registry |
| Entry Date(s): | Date Created: 20260407 Date Completed: 20260714 Latest Revision: 20260714 |
| Update Code: | 20260715 |
| DOI: | 10.1016/j.canep.2026.103067 |
| PMID: | 41946283 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1877-783X |
|---|---|
| DOI: | 10.1016/j.canep.2026.103067 |